" class="no-js "lang="en-US"> Frank Nestle - Medtech Alert
Saturday, August 23, 2025
Frank Nestle

Frank Nestle

About Frank Nestle

Head of Research and Chief Scientific Officer at Sanofi with responsibility for our main therapeutic areas of Immunology & Inflammation, Oncology including Immuno-Oncology, Neuroscience, Rare Diseases including Rare Blood Disorders and Genomic Medicine with a mandate to innovate and accelerate first and best in class medicines from discovery to clinical proof-of-concept.

Fellow of the National Academy of Medical Sciences, National Institute for Health Research (NIHR) Senior Investigator Emeritus; Professor Emeritus King’s College London,

Main clinical-academic research focus on the immunology and immunotherapy of psoriasis and melanoma. Over 350 scientific lectures at national and international conferences. Visiting Professor at the Mayo Clinic in 2000 and at Yale Medical School in 2005. Past President of the Federation of Clinical Immunology Societies.

Published over 220 scientific articles (H index 82; > 32000 citations) in publications such as Nature, Nature Medicine, Cell, New England Journal of Medicine, Lancet, Journal of Clinical Investigation and Journal of Experimental Medicine. Served on the editorial boards of Science Immunology, the Journal of Clinical Investigation and Journal of Investigative Dermatology.

Received 14 prizes including the Alfred Marchionini Research Award (20th World Congress of Dermatology) and the American Skin Association Achievement Award (Tricontinental Meeting of the Societies of Investigative Dermatology).

Specialties:
Dermatology
Clinical Immunology
Clinical Research
Clinical Trials
Mechanisms and Therapy of Inflammation
Mechanisms and Therapy of Skin Cancer
Immunotherapy

Related Story

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

August 19 2022

Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced […]

Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets

July 6 2022

Skyhawk Therapeutics, Inc. today announced the signing of an exclusive worldwide collaboration agreement with Sanofi […]

Sanofi Establishes Three-year Collaboration with Stanford Medicine to Accelerate Immunology Research

May 7 2021

Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, […]